Charles A. Lunn

Structural characterization of nitric oxide synthase isoforms reveals striking active-site conservation.

Thierry Fischmann, Alan Hruza, Xiao Da Niu et al. · Nature Structural Biology · 1999 · 456 citations

Life Sciences, Biochemistry, Molecular Biology +10

Endocannabinoid 2-Arachidonyl Glycerol Is a Full Agonist through Human Type 2 Cannabinoid Receptor: Antagonism by Anandamide

Waldemar Gonsiorek, Charles A. Lunn, Xuedong Fan et al. · Molecular Pharmacology · 2000 · 370 citations

Medicine, Biochemistry, Pharmacology +13

Crystal structure of a complex between interferon-γ and its soluble high-affinity receptor

Mark R. Walter, William T. Windsor, Tattanahalli L. Nagabhushan et al. · Nature · 1995 · 357 citations

Life Sciences, Immunology, Molecular Biology +14

Lasmiditan is an effective acute treatment for migraine

Bernice Kuca, Stephen D. Silberstein, Linda Wietecha et al. · Neurology · 2018 · 267 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

A Novel Cannabinoid Peripheral Cannabinoid Receptor-Selective Inverse Agonist Blocks Leukocyte Recruitment in Vivo

Charles A. Lunn, Jay S. Fine, Alberto Rojas-Triana et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 140 citations

Medicine, Medicinal Chemistry, Pharmacology +16